Trials Sponsors Conditions Drugs Pricing

Conditions

Low Birth Weight Infants

Keywords

Alkaline PhosphatasePregnancySuboptimal fetal growthPlacental insufficiencyLow birth weightIUGR

Outcome Measures

Primary Outcomes (1)

Birth Weight at Delivery
Birth Weight at Delivery
At Delivery

Study Arms (1)

Pregnant women at 24-28 weeks gestation

Pregnant women, aged 18 and older, who are seen for their prenatal care and who are between 24w0d and 28w6d weeks gestation.Their alkaline phosphatase levels will be tested in this study.

Diagnostic Test: Testing of Alkaline Phosphatase Levels

Interventions

Testing of Alkaline Phosphatase LevelsDiagnostic test

Testing of alkaline phosphatase levels at the time of the 24w0d to 28w6d week labs.

Pregnant women at 24-28 weeks gestation

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsPregnant women, aged 18 and older, who are seen for their prenatal care and who are between 24w0d and 28w6d weeks gestation.

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Pregnant women, aged 18 and older, who are seen for their prenatal care and who are between 24w0d and 28w6d weeks gestation.

You may qualify if:

Sponsors & Collaborators

TriHealth Inc.
Otherlead

Study Sites (1)

Good Samaritan TriHealth Hospital

Cincinnati, Ohio, 45220, United States

MeSH Terms

Conditions

Placental Insufficiency

Condition Hierarchy (Ancestors)

Placenta DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

Donna Lambers, MD
TriHealth Inc.
PRINCIPAL INVESTIGATOR

Enrollment

292 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 13, 2017

First Posted

June 15, 2017

Study Start

June 14, 2017

Actual (reported)

Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Pregnant women at 24-28 weeks gestation

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Pregnant women at 24-28 weeks gestation

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations